PureTech Health plc

PRTC

$17.38

+2.12%

2026-07-17 09:30:00 EDT+$0.36

Healthcare

Biotechnology

NASDAQ

Inactive

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic ...

PureTech Health: Results of Annual General Meeting

BOSTON--(BUSINESS WIRE)--PureTech Health: Results of Annual General Meeting.

Business Wire•6/10/2026

PureTech Health: Results of Annual General Meeting

BOSTON--(BUSINESS WIRE)--PureTech Health: Results of Annual General Meeting.

Neutral

General

PRTC: Neutral

Upstream

Teva Pharmaceutical Industries Ltd (via Auspex Pharmaceuticals subsidiary)NYSE:TEVANew York University (NYU)Contract Research Organizations (CROs) - Industry StandardUnconfirmedContract Development & Manufacturing Organizations (CDMOs) - Industry StandardUnconfirmedMonash University

Downstream

Bristol Myers Squibb (via Karuna Therapeutics acquisition)NYSE:BMY Royalty Pharma plcNASDAQ:RPRX Seaport TherapeuticsNASDAQ:SPTX Vor Bio (formerly Vor Biopharma)NASDAQ:VORCelea TherapeuticsGallop OncologyVedanta BiosciencesSonde Health

Proxies

Royalty Pharma plcNASDAQ:RPRX BridgeBio Pharma IncNASDAQ:BBIO Seaport TherapeuticsNASDAQ:SPTX

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

PureTech Health plc

Recent News of PRTC

PureTech Health: Results of Annual General Meeting

PureTech Health: Results of Annual General Meeting

Supply Chain of PRTC

Upstream

Downstream

Proxies

Recent News of PRTC

PureTech Health: Results of Annual General Meeting

PureTech Health: Results of Annual General Meeting

Supply Chain of PRTC

Upstream

Downstream

Proxies